Cosette Pharmaceuticals Expands Reach with Mayne Pharma Acquisition
Deal News | Feb 21, 2025 | Ropes & Gray
Ropes & Gray has announced its successful representation of Cosette Pharmaceuticals, Inc. in the acquisition of Mayne Pharma Group Limited. The definitive agreement involves Cosette Pharmaceuticals acquiring all outstanding shares of the Australian company, Mayne Pharma, at AUD$7.40 per share, translating to a total consideration of approximately USD$430 million. Cosette Pharmaceuticals, a U.S.-based company specializing in women's health and dermatology, is set to enhance its global footprint significantly through this acquisition. The legal expertise of Ropes & Gray was evident in the diverse team involved, which covered multiple facets of the deal such as private equity, mergers & acquisitions, finance, litigation, tax, employment, executive compensation, healthcare, regulatory compliance, IP transactions, environmental concerns, real estate, and European life sciences. This transaction bears strategic importance, especially in the pharmaceutical sector, positioning Cosette Pharmaceuticals for a stronger market presence internationally.
Sectors
- Pharmaceuticals
- Legal Services
Geography
- United States – Cosette Pharmaceuticals, a U.S.-based pharmaceutical company, is involved in the acquisition.
- Australia – Mayne Pharma Group Limited, the company being acquired, is based in Australia.
Industry
- Pharmaceuticals – The acquisition involves Cosette Pharmaceuticals and Mayne Pharma, both operating in the pharmaceutical industry, focusing on women's health and dermatology products.
- Legal Services – Ropes & Gray is a law firm providing crucial legal advisory services to Cosette Pharmaceuticals in this acquisition transaction.
Financials
- AUD$7.40 – The price per share at which Cosette Pharmaceuticals is acquiring Mayne Pharma.
- USD$430 million – Total consideration for the acquisition of Mayne Pharma by Cosette Pharmaceuticals.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Cosette Pharmaceuticals, Inc. | Acquiring Company | Company | A U.S.-based pharmaceutical company with a focus on products in women's health and dermatology. |
| Mayne Pharma Group Limited | Target Company | Company | An Australian pharmaceutical company being acquired by Cosette Pharmaceuticals. |
| Ropes & Gray | Legal Advisor | Company | A global law firm advising Cosette Pharmaceuticals on the acquisition. |
| Sam Levitt | Private Equity Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Jackie Cohen | Mergers & Acquisitions Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| David Blittner | Private Equity Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Arek Maczka | Finance Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Jackie Grise Lester | Litigation & Enforcement Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Lisa Kaltenbrunner | Litigation & Enforcement Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Jane Willis | Litigation & Enforcement Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Laura Hoey | Litigation & Enforcement Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Brendan Hanifin | Litigation & Enforcement Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Benjamin Rogers | Tax Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| David Saltzman | Tax Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Megan Bisk | Employment Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Pascal Mayer | Executive Compensation & Employee Benefits Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Deborah Gersh | Health Care Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Margaux Hall | Health Care Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Kellie Combs | Life Sciences Regulatory & Compliance Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Jordan Altman | IP Transactions Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Peter Alpert | Environmental Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| David Kaye | Real Estate Partner | Person | A partner at Ropes & Gray involved in the transaction. |
| Lincoln Tsang | European Life Sciences Partner | Person | A partner at Ropes & Gray involved in the transaction. |